These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antiarrhythmic drug therapy of ventricular arrhythmias. Huang SK; Marcus FI Curr Probl Cardiol; 1986 Apr; 11(4):177-240. PubMed ID: 3086035 [No Abstract] [Full Text] [Related]
5. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment. Nestico PF; Morganroth J Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932 [TBL] [Abstract][Full Text] [Related]
6. New drugs in the management of ventricular arrhythmias. Sanna GP G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894 [TBL] [Abstract][Full Text] [Related]
7. [Effects of anti-arrhythmia agents on heart rate. Significance and importance]. Leclercq JF; Georgiopoulos G; Halkidis H; Attuel P; Maisonblanche P; Coumel P Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():37-46. PubMed ID: 6122434 [No Abstract] [Full Text] [Related]
8. The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity. Schwartz PJ; Vanoli E; Zaza A; Zuanetti G Am Heart J; 1985 May; 109(5 Pt 1):937-48. PubMed ID: 3993528 [TBL] [Abstract][Full Text] [Related]
9. Advances in antiarrhythmic therapy. The role of newer antiarrhythmic drugs. Nademanee K; Singh BN JAMA; 1982 Jan; 247(2):217-22. PubMed ID: 6796709 [No Abstract] [Full Text] [Related]
11. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II. Singh BN; Cho YW; Kuemmerle HP Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721 [No Abstract] [Full Text] [Related]
12. Antiarrhythmic drugs: clinical pharmacology and therapeutic uses. Anderson JL; Harrison DC; Meffin PJ; Winkle RA Drugs; 1978 Apr; 15(4):271-309. PubMed ID: 648399 [No Abstract] [Full Text] [Related]
13. [Anti-arrhythmic effects of propafenone in coronary patients with ventricular arrhythmias]. Fiol M; Palma JL; Bayés de Luna A; Aza V; Sadurní J Rev Esp Cardiol; 1984; 37(3):196-200. PubMed ID: 6505351 [No Abstract] [Full Text] [Related]
14. [Validity and limits of invasive pharmacological tests in the treatment of malignant ventricular hyperkinetic arrhythmias]. Disertori M; Vergara G; Inama G; Guarnerio M; Furlanello F; Botti G; Bonatti V; Rolli A G Ital Cardiol; 1983; 13(4):311-4. PubMed ID: 6884675 [TBL] [Abstract][Full Text] [Related]
15. Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report. Aguglia F; Gnecchi M; De Marzio P Int J Cardiol; 1985 Mar; 7(3):303-6. PubMed ID: 2579918 [TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic therapy: new additions and future expectations. Ross WB; Mohiuddin SM Geriatrics; 1983 Jan; 38(1):30-5. PubMed ID: 6184263 [No Abstract] [Full Text] [Related]